A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia

Lazarus, S., Pretorius, C. J., Khafagi, F., Campion, K. L., Brennan, Sarah C. ORCID: https://orcid.org/0000-0002-8719-4367, Conigrave, A. D., Brown, E. M. and Ward, D. T. 2010. A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia. European Journal of Endocrinology 164 (3) , pp. 429-435. 10.1530/EJE-10-0907

Full text not available from this repository.

Abstract

Objective: The calcium-sensing receptor (CASR) is a key controller of calcium homeostasis by regulating parathyroid hormone (PTH) secretion and renal calcium reabsorption. CASRT888 is a protein kinase C (PKC) phosphorylation site in the receptor's intracellular domain that has previously been identified as a critical negative regulator of CASR downstream signaling in vitro, but whose importance in vivo is unknown. Case report The proband presented with mild symptomatic hypocalcemia following treatment for nephrotic syndrome due to minimal change glomerulonephropathy. Laboratory tests revealed inappropriately normal PTH concentrations and relative hypercalciuria typical of autosomal dominant hypocalcemia. His asymptomatic father had similar laboratory test results. Design and methods: The CASR gene was sequenced. To investigate the molecular consequences of CASRT888M mutation, site-directed mutagenesis was used to modify the wild-type (wt)-CASR gene, with the resulting mutant being transfected transiently into HEK-293 cells. Results: A novel CASR missense mutation, T888M, was identified in both cases. The CASRT888M mutant exhibited enhanced sensitivity to extracellular calcium concentration, both for intracellular calcium (Ca2+i) mobilization and for ERK phosphorylation, despite having unaltered levels of cell surface expression. Furthermore, CASRT888M elicited sustained Ca2+i mobilization rather than high frequency Ca2+i oscillations, and, unlike the wt-CASR, the response was resistant to acute inhibition by the PKC activator, phorbol 12-myristate 13-acetate. Conclusions: The clinical and functional data provide the first genotype–phenotype correlation for a mutation at T888, indicating its critical physiological importance in CASR signaling. Thus, CASRT888 represents a functionally important, inhibitory phosphorylation site that contributes to the control of PTH secretion

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Publisher:	European Society of Endocrinology
ISSN:	0804-4643
Last Modified:	27 Oct 2022 09:26
URI:	https://orca.cardiff.ac.uk/id/eprint/65840

Citation Data

Cited 26 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item